产品封面图

22Rv1

收藏
  • 询价
  • 2026年01月13日
    avatar
    15金牌会员
  • 企业认证

    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 库存

      大量

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 生长状态

      贴壁生长

    • 细胞形态

      上皮样

    • 运输方式

      冻存运输

    • 相关疾病

      肿瘤

    • 器官来源

      前列腺

    • ATCC Number

      CRL-2505™

    Designations: 22Rv1
    Depositors:  JW Jacobberger
    Biosafety Level: 2
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens deposited as human
    Morphology: epithelial

    Source: Organ: prostate
    Disease: carcinoma
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications:
    The cell line expresses prostate specific antigen (PSA).
    22Rv1 is a human prostate carcinoma epithelial cell line derived from a xenograft that was serially propagated in mice after castration-induced regression and relapse of the parental, androgen-dependent CWR22 xenograft.
    Receptors: androgen receptor
    Tumorigenic: Yes
    Antigen Expression: prostate specific antigen (PSA)
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 10,11
    D13S317: 9,12
    D16S539: 12
    D5S818: 11,12,13
    D7S820: 9,10,11
    THO1: 6,9.3
    TPOX: 8
    vWA: 15,21
    Cytogenetic Analysis: 49,XY,del(1)(p10),+i(1)(q10),der(2)t(2;4)(p13;q31)del(2)(q13q33),der(4)t(2;4)(p13;q31),t(6;14)(q15;q32),+7,+12[5]/50,idem,+3[1]
    Comments: 22Rv1 is a human prostate carcinoma epithelial cell line derived from a xenograft that was serially propagated in mice after castration-induced regression and relapse of the parental, androgen-dependent CWR22 xenograft.
    The cell line expresses prostate specific antigen (PSA). Growth is weakly stimulated by dihydroxytestosterone and lysates are immunoreactive with androgen receptor antibody by Western blot analysis.
    Growth is stimulated by epidermal growth factor (EGF) but is not inhibited by transforming growth factor beta-1 (TGF beta- 1).
    Recently , it has been shown that 22Rv1 prostate carcinoma cells produce high-titer of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus).
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
    Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Doubling Time: 40 hours
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    purified DNA:ATCC CRL-2505D
    References: 46128: Sramkoski RM, et al. A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell. Dev. Biol. Anim. 35: 403-409, 1999. PubMed: 10462204
    16173085: Knouf EC, et al. Multiple Integrated Copies and High-Level Production of the Human Retrovirus XMRV from 22Rv1 Prostate Carcinoma Cells. J. Virol. 83: 7353-7356, 2009. PubMed: 19403664

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 中国科学院细胞库可供应细胞目录

      中国科学院细胞库可供应细胞目录(英文字顺)名称 目录号 种属 中文名称 价格22RV1 TCHu100 人 前列腺癌细胞 800元293 GNHu1 人 胚肾细胞 450元293Cells,low passage GNHu18 人 胚肾细胞 1000元293T GNHu17 人 胚肾细胞 1000元3T3-L1 GNM11 小鼠 脂肪细胞 1000元3T3-Swiss albino GNM 9 小鼠

    • 细胞名称大汇总

      2.1-7      肝癌细胞 MDA-MB-231       乳腺癌细胞       Hep G2         肝癌细胞 HCT 116        结肠癌细胞       22RV1         前列腺癌细胞 HT-29         结肠癌细胞       KG-1          白血病细胞 LoVo          结肠癌细胞       THP-1         单核细胞白血病 SW620         结肠癌细胞       SK-N-SH      

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1480
    上海酶研生物科技有限公司
    2025年11月21日询价
    ¥1320
    博辉生物科技(广州)有限公司
    2025年10月28日询价
    ¥1280
    上海康朗生物科技有限公司
    2026年01月12日询价
    ¥2200
    上海钰博生物科技有限公司
    2025年07月15日询价
    ¥800
    上海沪震实业有限公司
    2025年07月13日询价
    22Rv1
    询价